EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens

Ye Qiongxian, Deng Jun, Zhang Zhenfeng, Luo Tongyou, Tan Zhicong, Tan Zhenyou

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Ye Qiongxian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Huanan Pharmaceutical Co. Ltd., Guangdong, Dongguan, China. Hauptthemen laut MEDLINE: Indoles, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter (ESKAPE) species as causative agents are characterized by increased levels of resistance toward multiple classes of first‐line as well as last‐resort antibiotics and represent serious global health concerns, creating a critical need for the development of novel antibacterials with therapeutic potential against drug‐resistant ESKAPE species. Indole derivatives with structural and mechanistic diversity demonstrated broad‐spectrum antibacterial activity against various clinically important pathogens including drug‐resistant ESKAPE. Moreover, several indole‐based agents that are exemplified by creatmycin have already been used in clinics or under clinical trials for the treatment of bacterial infections, demonstrating that indole derivatives hold great promise for the development of novel antibacterials. This review is an endeavor to highlight the current scenario of indole hybrids, dimers, and trimers with therapeutic potential against drug‐resistant ESKAPE pathogens, covering articles published from 2020 to the present, to open new avenues for the exploration of novel antidrug‐resistant ESKAPE candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesAnti-Bacterial AgentsHumansDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsKlebsiella pneumoniaeStructure-Activity RelationshipStaphylococcus aureusPseudomonas aeruginosaEnterobacterEnterococcus faeciumMolecular StructureAnimals

Stichwörter der Autor:innen

ESKAPEdimershybridsindoletrimers

Substanzen

IndolesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Guangdong Huanan Pharmaceutical Co. Ltd., Guangdong, Dongguan, China.
  • Guangdong Zhongsheng Pharmaceutical Co. Ltd., Guangdong, Dongguan, China.
  • Guangdong Xianqiang Pharmaceutical Co. Ltd., Guangdong, Guangzhou, China.
  • Key Laboratory of Functional Molecular Engineering of Guangdong Province, School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou, China.

Förderung

  • None

Zitieren

APA

Qiongxian, Y., Jun, D., Zhenfeng, Z., Tongyou, L., Zhicong, T., & Zhenyou, T. (2024). The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400295

Vancouver

Qiongxian Y, Jun D, Zhenfeng Z, Tongyou L, Zhicong T, Zhenyou T. The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400295

BibTeX
@article{Qiongxian2024,
  author = {Qiongxian, Ye and Jun, Deng and Zhenfeng, Zhang and Tongyou, Luo and Zhicong, Tan and Zhenyou, Tan},
  title = {The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400295}
}
Kostenlos starten →